Pyrrole‐based EGFR inhibitors for the treatment of NCSLC: Binding modes and SARs investigations.

MLA

He, Jie, et al. “Pyrrole‐based EGFR Inhibitors for the Treatment of NCSLC: Binding Modes and SARs Investigations.” Chemical Biology & Drug Design, vol. 101, no. 1, Jan. 2023, pp. 195–217. EBSCOhost, https://doi.org/10.1111/cbdd.14169.

APA

He, J., Luo, L., Xu, S., Yang, F., & Zhu, W. (2023). Pyrrole‐based EGFR inhibitors for the treatment of NCSLC: Binding modes and SARs investigations. Chemical Biology & Drug Design, 101(1), 195–217. https://doi.org/10.1111/cbdd.14169

Chicago

He, Jie, Leixuan Luo, Shidi Xu, Feiyi Yang, and Wufu Zhu. 2023. “Pyrrole‐based EGFR Inhibitors for the Treatment of NCSLC: Binding Modes and SARs Investigations.” Chemical Biology & Drug Design 101 (1): 195–217. doi:10.1111/cbdd.14169.